Alliance Pharma PLC

Alliance Pharma PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)47.65
  • Today's Change0.50 / 1.06%
  • Shares traded3.44m
  • 1 Year change-52.25%
  • Beta0.8848
Data delayed at least 20 minutes, as of Nov 29 2022 14:13 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

As of last trade, Alliance Pharma PLC (APH:LSE) traded at 47.65, 39.59% above the 52 week low of 34.14 set on Nov 24, 2022.
52-week range
34.14Nov 24 2022122.00Apr 08 2022
Markit short selling activity
Previous close47.15
Average volume6.40m
Shares outstanding540.00m
Free float463.36m
P/E (TTM)21.16
Market cap254.61m GBP
EPS (TTM)0.0223
Annual div (ADY)1.72
Annual div yield (ADY)3.65%
Div ex-dateJun 09 2022
Div pay-dateJul 07 2022
Next div ex-dateDec 22 2022
Next div pay-dateJan 19 2023
Data delayed at least 20 minutes, as of Nov 29 2022 14:13 GMT.
More ▼

Investors Chronicle View

The last IC recommendation on Alliance Pharma PLC shares was Hold at 71.00 on 20 Sep 2022Read the full article
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.